Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34 Filing Table of Contents
Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 896K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 23K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 23K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 20K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 20K
12: R1 Cover Page HTML 71K
13: R2 Consolidated Statements of Income HTML 92K
14: R3 Consolidated Statements of Comprehensive Income HTML 41K
15: R4 Consolidated Balance Sheets HTML 99K
16: R5 Consolidated Balance Sheets (Parenthetical) HTML 33K
17: R6 Consolidated Statements of Stockholders' Equity HTML 80K
18: R7 Consolidated Statements of Cash Flows HTML 115K
19: R8 Organization and Basis of Presentation HTML 35K
20: R9 Significant Accounting Policies HTML 116K
21: R10 Net Income per Share HTML 64K
22: R11 Fair Value Measurements HTML 146K
23: R12 Investments HTML 158K
24: R13 Medical Claims and Benefits Payable HTML 54K
25: R14 Debt HTML 51K
26: R15 Stockholders' Equity HTML 59K
27: R16 Segments HTML 75K
28: R17 Commitments and Contingencies HTML 23K
29: R18 Significant Accounting Policies (Policies) HTML 98K
30: R19 Significant Accounting Policies (Tables) HTML 107K
31: R20 Net Income per Share (Tables) HTML 64K
32: R21 Fair Value Measurements (Tables) HTML 147K
33: R22 Investments (Tables) HTML 157K
34: R23 Medical Claims and Benefits Payable (Tables) HTML 55K
35: R24 Debt (Tables) HTML 44K
36: R25 Stockholders' Equity (Tables) HTML 54K
37: R26 Segments (Tables) HTML 71K
38: R27 Organization and Basis of Presentation (Details) HTML 48K
39: R28 Significant Accounting Policies - Cash and Cash HTML 28K
Equivalents (Details)
40: R29 Significant Accounting Policies - Narrative HTML 47K
(Details)
41: R30 Significant Accounting Policies - Amounts Due To HTML 38K
Government Agencies (Details)
42: R31 Significant Accounting Policies - Quality HTML 37K
Incentive Premium Revenue Recognized (Details)
43: R32 Significant Accounting Policies - Receivables HTML 31K
(Details)
44: R33 Net Income per Share (Details) HTML 63K
45: R34 Fair Value Measurements - Fair Value of Financial HTML 97K
Instruments on Recurring Basis (Details)
46: R35 Fair Value Measurements - Balance Sheet Grouping HTML 30K
(Details)
47: R36 Fair Value Measurements - Details of Long-Term HTML 70K
Debt (Details)
48: R37 Investments - Summary of Investments (Details) HTML 54K
49: R38 Investments - Contractual Maturities of HTML 47K
Available-for-Sale Investments (Details)
50: R39 Investments - Narrative (Details) HTML 28K
51: R40 Investments - Available-for-Sale Investments HTML 49K
(Details)
52: R41 Medical Claims and Benefits Payable - Medical HTML 28K
Claims and Benefits Payable (Details)
53: R42 Medical Claims and Benefits Payable - Narrative HTML 22K
(Details)
54: R43 Medical Claims and Benefits Payable - Components HTML 40K
of Change in Medical Claims and Benefits Payable
(Details)
55: R44 Debt - Schedule of Long-Term Debt (Details) HTML 53K
56: R45 Debt - Narrative (Details) HTML 79K
57: R46 Stockholders' Equity - Narrative (Details) HTML 66K
58: R47 Stockholders' Equity - Share Activity (Details) HTML 48K
59: R48 Stockholders' Equity - Fair Value of Awards HTML 28K
Granted and Vested (Details)
60: R49 Segments - Narrative (Details) HTML 20K
61: R50 Segments - Reconciliation of Gross Margin to HTML 49K
Consolidated Income (Details)
63: XML IDEA XML File -- Filing Summary XML 112K
11: XML XBRL Instance -- moh-20200630_htm XML 2.40M
62: EXCEL IDEA Workbook of Financial Reports XLSX 83K
7: EX-101.CAL XBRL Calculations -- moh-20200630_cal XML 210K
8: EX-101.DEF XBRL Definitions -- moh-20200630_def XML 464K
9: EX-101.LAB XBRL Labels -- moh-20200630_lab XML 1.37M
10: EX-101.PRE XBRL Presentations -- moh-20200630_pre XML 794K
6: EX-101.SCH XBRL Schema -- moh-20200630 XSD 140K
64: JSON XBRL Instance as JSON Data -- MetaLinks 328± 478K
65: ZIP XBRL Zipped Folder -- 0001179929-20-000111-xbrl Zip 293K
1. I have reviewed the report on Form 10-Q for the period ended June 30, 2020 of Molina Healthcare, Inc.;
2.
Based on my knowledge, the report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;
3. Based on my knowledge, the financial statements, and other financial information included in the report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in the report;
4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended), and internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Securities Exchange Act of 1934, as amended), for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period for which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in the report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by the report based on such evaluation; and
(d) Disclosed in the report any change in the registrant’s internal control over financial
reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and to the audit committee of the
registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
